Drug Type Autologous CAR-T |
Synonyms GPC3 CAR-T (China Immunotech), GPC3 CXCRx START, GPC3CART cells + [5] |
Target |
Mechanism CXCR2 antagonists(C-X-C motif chemokine receptor 2 antagonists), GPC3 inhibitors(Glypican-3 inhibitors), Gene transference + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization BriSTAR Immunotech LimitedStartup |
Active Organization BriSTAR Immunotech LimitedStartup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Phase 1 | CN | BriSTAR Immunotech LimitedStartup | - |
Stomach Cancer | Phase 1 | CN | BriSTAR Immunotech LimitedStartup | - |